Yet, MexCD mutants are quite significant in cystic fibrosis patients and the pump is known to potentiate the effect of mutations in target genes as gyrA [ 108 ].
← all excerpts
Clinical Status of Efflux Resistance Mechanisms in Gram-Negative Bacteria.
1
—
—